Bioanalytical Labs Immuno-oncology Assay List

PPD Laboratories now offers assays for quantitation and detection of pembrolizumab, bevacizumab and ipilimumab, extensively used and clinically successful immuno-oncology therapies. These assays are available for clinical analysis for protocols that include pembrolizumab, bevacizumab and ipilimumab as primary or co-medications.